The Three C's of Customer Experience in Oncology

Posted by Pranav Srivastava on Mar 20, 2019 8:00:00 AM

Malik Kaman co-wrote this blog post with Pranav Srivastava.

During a recent client meeting, a vice president of marketing challenged my perspective on the role of customer experience in oncology. Doesn’t every manufacturer want to achieve the same fundamental customer experience? And if we’re all going for the same thing, how can this be a lever of differentiation?  


>
Read More

A New Era of Biosimilars in Oncology: Four Themes From ESMO 2017

Posted by Christina Corridon on Sep 21, 2017 12:30:53 PM

The European healthcare landscape has more than a decade of in-market experience with supportive care biosimilars. However, we’re entering a new era for biosimilars in oncology with the recent launch of therapeutic biosimilars in the EU.

At the recent European Society for Medical Oncology (ESMO) Congress, held Sept. 8-12 in Madrid, the European medical industry came together for clinical data updates, expertise-sharing and advisory guidance. There were six presentations on biosimilars at the event, including those sponsored by biosimilar manufacturers. Consistent across many sessions were four core themes:


>
Read More